Core Scientific, Inc/tx DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Core Scientific reports significant progress in 2025, expanding its high-density colocation infrastructure for AI and HPC, with over $10 billion in projected revenue from a 12-year CoreWeave agreement.
NASDAQ
Two Seas Capital LP, a major shareholder, is actively soliciting votes AGAINST Core Scientific's proposed acquisition by CoreWeave, citing a flawed process, deficient structure, and inadequate valuation.
NASDAQ
Core Scientific's board unanimously recommends an all-stock merger with AI hyperscaler CoreWeave, offering stockholders a 27.2% premium and a stake in a rapidly growing AI infrastructure leader.
NASDAQ
Core Scientific's 2025 proxy statement outlines strategic priorities including infrastructure expansion, customer diversification, and potential acquisitions, reflecting its transformation into a leading provider of high-performance computing and AI-driven data center solutions.